Skip to main content
PLOS Global Public Health logoLink to PLOS Global Public Health
. 2026 Feb 25;6(2):e0005596. doi: 10.1371/journal.pgph.0005596

Prevalence and predictors of prediabetes/type 2 diabetes mellitus among adolescents in the United States: NHANES (2021–2023)

Eric Peprah Osei 1,2,*
Editor: Doreen Larvie3
PMCID: PMC12935269  PMID: 41739753

Abstract

Prediabetes and type 2 diabetes mellitus (T2DM) are emerging public health concerns among adolescents in the United States (U.S.), with early onset increasing the risk of lifelong complications. This study analyzed the prevalence and factors associated with prediabetes/T2DM among 1,998 adolescents (10–19 years) in the U.S. using data from the National Health and Nutrition Examination Surveys (2021–2023). Prediabetes/T2DM were defined as hemoglobin A1c (HbA1c) ≥ 5.7% or fasting plasma glucose (FPG) ≥ 100 mg/dL. Unweighted univariate and multiple logistic regression models were used to identify predictors of prediabetes/T2DM among adolescents. Overall, 30.8%—nearly 1 in 3 American adolescents—had prediabetes or T2DM. In univariate analysis, older age (OR = 0.93, p = 0.045), female gender (OR = 0.50, p = 0.001), overweight/obesity (OR = 1.57, p = 0.012), elevated waist-to-height ratio (OR = 24.04, p = 0.002), total daily sugar intake (OR = 1.003; p = 0.042), low HDL cholesterol (≤45 mg/dL) (OR = 1.41; p = 0.032), higher systolic blood pressure (OR = 1.02, p = 0.002) and higher diastolic blood pressure (OR = 1.02, p = 0.037) were significantly associated with the odds of having prediabetes/T2DM. However, in multiple logistic regression analysis, significant predictors included older age (AOR = 0.91; p = 0.025), female gender (AOR = 0.52; p = 0.002), and elevated waist-to-height ratio (AOR = 146.19; p = 0004). Although male gender and younger age showed increased risk, central adiposity—specifically measured by waist-to-height ratio—emerged as the strongest independent predictor of prediabetes/T2DM compared to general overweight/obesity (BMI). These findings underscore the need for early screening and targeted prevention strategies focusing on central adiposity and demographic risk factors.

Introduction

Over the past two decades, there has been a dramatic rise in the prevalence of prediabetes and type 2 diabetes mellitus (T2DM) among adolescents in the United States (U.S.) [1]. This trend is mainly driven by rising rates of obesity, sedentary lifestyle, and unhealthy dietary patterns [2,3]. The National Institute of Diabetes and Digestive and Kidney Diseases report in 2024 indicated that, the alarmingly high rate of T2DM disproportionately affects children and young people from racial and ethnic minority groups [4] and is projected to quadruple in the next four decades [5]. This evidence is particularly concerning given that previous studies have highlighted the more aggressive nature of youth-onset T2DM [6]. The associated complications such as diabetic kidney disease, cardiovascular disease, neuropathy and retinopathy [6,7] manifest earlier among adolescents due to rapid destruction of the pancreatic beta cells [8]. This negatively impacts their quality of life and subsequently leads to unfavorable long-term outcomes [8]. Concurrently, prediabetes, which is a key predictor of T2DM, is increasing rapidly among this vulnerable population [9]. This arguably portends an impending public health disaster and highlights a critical need for early identification and management.

Despite the increases in the burden of prediabetes and T2DM in the adolescent population, significant gaps persist in understanding the prevalence and risk factors for these conditions. Most epidemiological studies pertaining to T2DM have predominantly focused on older adults, leaving adolescents among the most understudied age brackets. A study conducted by Ouyang et. al. (2024) that analyzed National Health and Nutrition Examination Survey (NHANES) data (1999–2020) among adolescents only focused on obesity as a risk factor for diabetes and prediabetes [10]. However, the study did not thoroughly evaluate other predictors such as socio-economic status, dietary patterns, waist-to-height circumference, physical activity and sedentary time. Furthermore, NHANES offers a nationally representative dataset to evaluate trends in prediabetes and T2DM across various age groups. Nevertheless, few studies have utilized the most up-to-date NHANES data from 2021 through 2023 in examining T2DM risks among adolescents, especially in the COVID-19 pandemic era, which further deteriorated metabolic health.

To address these gaps, this current study aimed to analyze the current NHANES (2021–2023) data to determine the prevalence of prediabetes/T2DM among adolescents (10–19 years) in the U.S. Additionally, the study sought to identify predictors of prediabetes/T2DM among adolescents in the U.S. Findings from the study are critical to inform public health policies and development of targeted interventions for this vulnerable population. The rising prevalence of early-onset T2DM in youth may cause a spike in diabetes-related complications if prompt interventions are not developed.

Methods

Ethics statement

This study used publicly available, de-identified data from NHANES (2021–2023). NHANES data collection was approved by the National Center for Health Statistics Research Ethics Review Board, and all participants provided informed consent. Because the data are publicly available and de-identified, additional institutional review board approval was not required for this secondary analysis.

Data source

This study conducted a secondary analysis of data from the 2021–2023 cycle of NHANES, a program conducted by the Centers for Disease Control and Prevention (CDC). NHANES uses a complex, multistage probability sampling method designed to produce a nationally representative sample of the U.S. civilian, non-institutionalized population. The survey collects detailed health and nutrition information through standardized in-home interviews, physical examinations, and laboratory assessments conducted at mobile examination centers.

Study population

The study focused on adolescents aged 10–19 years. Participants with complete data on anthropometrics, fasting plasma glucose, and HbA1c were included. The final analytic sample consisted of 1,998 adolescents (1,001 males and 997 females). The dataset is de-identified and publicly available, negating the need for further ethical approval.

Measurements and glucose status definitions

Dependent variables

Although HbA1c and fasting plasma glucose (FPG) were originally reported as continuous variables, they were dichotomized to classify participants as having prediabetes/T2DM (1 = yes) and normal glucose tolerance (0 = no). Prediabetes/T2DM were defined as having HbA1c ≥ 5.7% or FPG ≥ 100 mg/dL whereas normal glucose levels were HbA1c < 5.7% or FPG < 100 mg/dL [11]. In the current study sample, 69.2% of participants had normal glucose, 30.5% had prediabetes, and 0.25% had T2DM. Due to the very low prevalence of T2DM (5 out of 1,998), separate modeling of prediabetes and T2DM would have resulted in unstable estimates and limited statistical power. Categorizing glucose status into “normal” and “prediabetes/T2DM “facilitates a more thorough and efficient analysis of the metabolic health of adolescents based on the risk factors and early intervention windows that are common to both disorders. This approach also maximizes statistical power and allows for data modeling.

Independent variables

Demographic variables.

Information about age, sex, race, and poverty income ratio (PIR) was obtained from demographic data. Age, a continuous variable, was dichotomized as early adolescents (10–14 years) and late adolescents (15–19 years). Sex was reported as a binary variable, representing male or female. There were six racial groups: Mexican American, other Hispanic, Non-Hispanic White, Non-Hispanic Black, Non-Hispanic Asian and other race. Ratio of family income to poverty level, a continuous variable, was defined as low income (PIR < 1.3), middle income (PIR ≥ 1.3 & < 3.5), and high income (PIR ≥ 3.5) [12]. Health insurance status was derived from the survey question, “Are you covered by health insurance or some other kind of health care plan?”, with either ‘Yes’ or ‘No’ response.

Anthropometric factors.

The body mass index (BMI) originally reported with four levels was further categorized as underweight/normal weight or overweight/obesity. Waist-to-height ratio, a measure of central obesity, was calculated by waist circumference (cm)/ height (cm) which was further dichotomized as healthy <0.5 or abdominal obesity ≥ 0.5 [13].

Lifestyle factors.

Sedentary behavior was measured by hours per day spent watching TV or videos. This variable was further categorized into two groups of activities: < 2 hours/day and ≥2 hours/day [14]. Physical activity, measured as days physically active at least 60 min, was dichotomized as those who met physical activity guidelines (≥60 minutes/day on all 7 days) and those that did not meet guidelines (<60 minutes on any day) [15].

Dietary patterns.

Dietary consumption patterns were recorded through 24-hour dietary recall interviews. Total sugar intake and total carbohydrate intake, measured in grams, were treated as continuous variables. Energy intake (kcal) was categorized based on the Dietary Guidelines for Americans, 2020–2025, which recommend 1,400–2,200 kcal/day for females aged 9–13 years, 1,800–2,400 kcal/day for females aged 14–18 years, 1,600–2,600 kcal/day for males aged 9–13 years, and 2,000–3,200 kcal/day for males aged 14–18 years [16]. Participants were classified as consuming (1) below, (2) within, or (3) above the recommended intake for their age and sex.

Clinical and biochemical factors.

Total cholesterol, high-density lipoprotein cholesterol (HDL-C) and C-reactive protein values were obtained from the laboratory data. Healthy children, 19 years old and younger, should have: total cholesterol below 170 mg/dL and high-density lipoprotein (HDL) above 45 mg/dL [17]. Likewise, C-reactive protein (hs-CRP) value of >3.0 mg/L was considered a marker for inflammation and elevated risk for CVD [18,19]. For adolescents aged 10–12 years: Normal BP: < 90th percentile; Elevated BP: ≥ 90th to <95th percentile or 120/80 mmHg to <95th percentile (whichever is lower); Hypertension: ≥ 95th percentile to <95th percentile + 12 mmHg or ≥130/80 mmHg (whichever is lower). For adolescents aged ≥13 years: Normal BP: < 120/ < 80 mmHg; Elevated BP: 120/ < 80–129/ < 80 mmHg; Hypertension: ≥ 130/80 mmHg. [12].

Data analysis

Data analysis was performed using STATA software, version 18. Descriptive statistics comprised means, standard deviations, frequencies, and percentages that determined not only the prevalence of prediabetes/T2DM but also characterized the study population (adolescents). To assess the robustness of the findings, sensitivity analyses were conducted using the fasting subsample (n = 571) with appropriate NHANES fasting subsample weights (wtsaf2yr), accounting for strata and primary sampling units (sdmvstra, sdmvpsu). For the second aim, multiple logistic regression models were employed to examine potential predictors of prediabetes/T2DM among adolescents. Furthermore, sequential logistic regression models were fitted to examine the association between overweight/obesity and abnormal glucose status (S2 Table). Missing data were handled by multivariate multiple imputation using chained equations to minimize bias and ensure the robustness of the findings.

Results

This study analyzed data from 1,998 U.S. adolescents (10–19 years) from the National Health and Nutrition Examination Surveys (NHANES, 2021–2023) to determine the prevalence and predictors of prediabetes/type 2 diabetes mellitus. The analysis included 1,998 U.S. adolescents (mean age 14.2 ± 2.8 years; 50.1% male). Overall, 41.2% were overweight/obese and 40.8% had abdominal obesity (waist-to-height ratio ≥0.5). Sedentary behavior was highly prevalent (88.5% ≥ 2 h/day), while only 20.7% met physical activity guidelines. The mean fasting plasma glucose (FPG) and HbA1c were 95.2 mg/dL and 5.25%, respectively, with males exhibiting higher mean FPG (96.80 vs. 93.68 mg/dL). Systolic blood pressure and HDL cholesterol levels differed by sex, with males having higher mean systolic BP (109.5 vs. 103.7 mmHg) and lower mean HDL (50.5 vs. 54.4 mg/dL). Total cholesterol and C-reactive protein levels were similar between both sexes (Table 1).

Table 1. Demographics and key characteristics of adolescents (10-19 years, n = 1998).

Variable Total Sample

n = 1998
Males

n = 1001
Females

n = 997
Age (years), n (%)
 Mean 14.2 ± 2.80 14.2 ± 2.78 14.2 ± 2.83
 Early adolescents (10–14) 1088 (54.5) 542 (54.1) 546 (54.8)
 Late adolescents (15–19) 910 (45.5) 459 (45.9) 451 (45.2)
Race/Ethnicity, n (%)
 Mexican American 305 (15.3) 141 (14.1) 164 (16.4)
 Other Hispanic 282 (14.1) 147 (14.7) 135 (13.6)
 Non-Hispanic White 785 (39.3) 380 (37.9) 405 (40.6)
 Non-Hispanic Black 302 (15.1) 151 (15.1) 151 (15.2)
 Non-Hispanic Asian 125 (6.3) 68 (6.8) 57 (5.7)
 Other Race 199 (9.9) 114 (11.4) 85 (8.5)
Health Insurance Status (Yes), n (%) 1876 (93.9) 930 (92.9) 946 (94.8)
Poverty income ratio (PIR), n (%)
 Low income (PIR < 1.3) 687 (34.4) 333 (33.3) 354 (35.5)
 Middle income (PIR ≥ 1.3 & < 3.5) 804 (40.3) 407 (40.6) 398 (39.9)
 High income (PIR ≥ 3.5) 507 (25.3) 261 (26.1) 246 (24.6)
BMI Categories, n (%)
 Mean 23.76 ± 7.35 23.62 ± .23 23.91 ± .24
 Underweight/Normal Weight 1174 (58.8) 587 (58.7) 587 (58.9)
 Overweight/Obesity 824 (41.2) 414 (41.3) 410 (41.1)
Waist-to-Height Ratio, n (%)
 Healthy <0.5 1183 (59.2) 614 (61.3) 569 (57.1)
 Abdominal obesity ≥ 0.5 815 (40.8) 387 (38.7) 428 (42.9)
Total sedentary time, n (%)
  < 2hours/day 231 (11.5) 123 (12.3) 107 (10.8)
  ≥ 2hours/day 1767 (88.5) 878 (87.7) 890 (89.2)
Days Physically Active, n (%)
 Did not meet guidelines 1584 (79.3) 755 (75.4) 829 (83.1)
 Met guidelines (≥60 Minutes * 7days) 414 (20.7) 246 (24.6) 168(16.9)
HbA1c (%), mean ± SD 5.25 ± .41 5.25 ± .48 5.24 ± .40
FPG (mg/dl), mean ± SD 95.24 ± 15.71 96.80 ± 20.62 93.68 ± 13.49
Systolic BP, mean ± SD 106.6 ± 10.34 109.48 ± 10.46 103.71 ± 9.66
Diastolic BP, mean ± SD 63.77 ± 8.50 64.0 ± 9.20 63.54 ± 8.20
Total cholesterol, mean ± SD 155.36 ± 38.38 154.30 ± 37.81 156.43 ± 39.94
HDL cholesterol, mean ± SD 52.42 ± 16.31 50.45 ± 12.51 54.40 ± 15.93
C-reactive protein, mean ± SD 1.99 ± 5.47 1.98 ± 8.09 1.99 ± 8.09

n (%) – Frequency (percentage); SD – Standard deviation; FPG – Fasting plasma glucose; HbA1c – Glycated hemoglobin; BMI – Body mass index; HDL – High-density lipoprotein; BP – Blood pressure.

Table 2 presents the unweighted prevalence of prediabetes/T2DM among adolescents aged 10–19 years, stratified by key demographic and health variables. The overall weighted prevalence of prediabetes/T2DM was a concerning 30.8%, meaning nearly 1-in-3 American adolescents has the condition (Fig 1). The prevalence of prediabetes/ T2DM was significantly higher in males (62.0%) compared to females (38.0%). Non-Hispanic White adolescents (37.2%) had the highest rates across racial/ethnic groups. Adolescents with overweight/obesity (48.8%) and those with abdominal obesity (waist-to-height ratio ≥ 0.5) (48.7%) had prevalence rates similar to their healthier-weight counterparts.

Table 2. Unweighted prevalence of prediabetes/T2DM among adolescents (10-19 years, n = 1,998), Stratified by Key Variables.

Variable Normal glucose

Unweighted %

(95% CI)
Prediabetes/ T2DM Unweighted %

(95% CI)
p-value
Overall Prevalence 69.2 [65.5 - 73.0] 30.8 [27.0 - 34.5]
Gender 0.000ª
 Male 44.8 [41.5-48.1] 62.0 [56.4-67.6]
 Female 55.2 [51.9-58.5] 38.0 [32.4-43.6]
Race/Ethnicity 0.500b
 Mexican American 14.6 [12.3-17.0] 16.7 [12.2-21.1]
 Other Hispanic 13.6 [11.5-15.7] 15.3 [11.5-19.0]
 Non-Hispanic White 40.2 [37.1-43.2] 37.2 [31.9-42.6]
 Non-Hispanic Black 15.4 [13.2-17.7] 14.4 [10.6-18.2]
 Non-Hispanic Asian 6.5 [5.0-8.0] 5.7 [3.2-8.3]
 Other Race 9.7 [7.7-11.7] 10.7 [6.9-14.5]
BMI Categories 0.000ª
 Underweight/ healthy weight 62.2 [58.8-65.5] 51.2 [44.3-58.1]
 Overweight/ obesity 37.8 [34.5-41.2] 48.8 [41.9-55.7]
Waist-to-Height Ratio 0.000ª
 Healthy (<0.5) 62.7 [59.5 – 66.0] 51.3 [44.5 – 58.2]
 Abdominal obesity (≥ 0.5) 37.3 [34.0 – 40.5] 48.7 [41.8 – 55.5]
Poverty income ratio (PIR) 0.722b
 Low income (PIR < 1.3) 33.8 [30.9-36.8] 35.5 [30.1-41.0]
 Middle income (PIR ≥ 1.3 & < 3.5) 40.8 [37.5-44.1] 39.0 [33.7-44.3]
 High income (PIR ≥ 3.5) 25.3 [22.5-28.2] 25.5 [20.5-30.4]
Health Insurance Status 0.920ª
 Yes 93.9 [92.4 – 95.3] 93.9 [91.4 – 96.4]
 No 6.1 [4.7 – 7.6] 6.1 [3.6 – 8.6]

ªFisher’s exact test; b Pearson chi-square; BMI -Body mass index. Although NHANES survey weights were available, unweighted multiple-imputation estimates are reported for all participants (n = 1,998) to maximize statistical power. Weighted analyses restricted to the fasting subsample (n = 571) that accounted for survey weights, strata, and primary sampling units produced comparable findings (S1 Table).

Fig 1. Prevalence of normal glucose vs prediabetes/T2DM in U.S. adolescents (Data source: NHANES 2021–2023).

Fig 1

Logistic regression model assumptions

Prior to model fitting, assumptions underlying logistic regression were evaluated. To assess multicollinearity among the independent variables, variance inflation factors (VIF) were examined. Total carbohydrate intake (tcarb) showed a VIF of 10.25, indicating high multicollinearity, and was therefore removed from the model. All remaining predictors had VIF values below 10, suggesting no significant collinearity issues. The assumption of linearity in the logit was tested for continuous variables. Several variables including poverty-income ratio (indfmpir), total cholesterol (lbxtc), HDL cholesterol (lbdhdd), BMI (bmxbmi), sedentary activity (paq706), physical activity (paq711), and total energy intake (tkcal), violated this assumption. Consequently, these variables were categorized based on established criteria in literature.

Logistic regression analysis of factors associated with prediabetes/T2DM

Table 3 presents the univariate and multivariate logistic regression models exploring associations between demographic, anthropometric, lifestyle, dietary, and clinical factors with prediabetes/T2DM among adolescents aged 10–19 years. Univariate analysis identified several significant predictors of prediabetes/T2DM. Lower odds were observed for older age (OR = 0.93, 95% CI: 0.87–0.99) and female gender (OR = 0.50, 95% CI: 0.36–0.68). Conversely, higher odds were associated with overweight/obesity (OR = 1.57, 95% CI: 1.11–2.21), elevated waist-to-height ratio (OR = 24.04, 95% CI: 3.62–159), higher daily sugar intake (OR = 1.003, 95% CI: 1.000–1.005), low HDL cholesterol (≤45 mg/dL) (OR = 1.41, 95% CI: 0.79–1.65), and higher systolic (OR = 1.02, 95% CI: 1.01–1.03) and diastolic blood pressure (OR = 1.02, 95% CI: 1.00–1.04).

Table 3. Logistic regression of factors associated with prediabetes/T2DM in adolescents.

Variable Univariate Multivariate
Unadjusted OR (95% CI) p-value Adjusted OR

(95% CI)
P value
Demographic variables
 Age (years) 0.93 [0.87, 0.99] 0.045 0.91 [0.83, 0.99] 0.025
 Gender (Female) 0.50 [0.36, 0.68] 0.000 0.53 [0.36, 0.78] 0.002
 Race (Ref: Other Race)
  Mexican American 1.03 [0.53, 2.02] 0.925 1.16 [0.55, 2.43] 0.686
  Other Hispanic 1.02 [0.52, 2.01] 0.957 1.13 [0.54, 2.35] 0.738
  Non-Hispanic White 0.84 [0.47, 1.50] 0.549 0.95 [.051, 1.77] 0.865
  Non-Hispanic Black 0.84 [0.46, 1.55] 0.579 0.95 [0.49, 1.83] 0.867
  Non-Hispanic Asian 0.79 [0.38, 1.68] 0.548 0.94 [0.43, 2.07] 0.884
 Poverty-income-ratio (Ref: Low income)
  Middle income 0.91 [0.65, 1.28] 0.582 0.93 [0.64, 1.36] 0.705
  High income 0.95 [0.65, 1.40] 0.816 1.09 [0.68, 1.74] 0.717
 Health Insurance Status (Yes) 1.01 [0.57, 1.80] 0.964 1.04 [0.56, 1.95] 0.891
Anthropometric factors
 BMI Status (Ref: Normal weight)
  Overweight/Obesity 1.57 [1.11, 2.21] 0.012 0.74 [0.43, 1.29] 0.285
 Waist-to-height ratio 24.04 [3.62, 159] 0.002 146.42 [5.39, 3976] 0.004
Lifestyle factors
 Total sedentary time (Ref: < 2hours/day)
   ≥ 2hours/day 0.77 [0.42, 1.42] 0.395 0.80 [0.42, 1.52] 0.493
 Physical Activity (Ref: Below Guidelines)
 Met guidelines (≥60 Min * 7 days) 1.17 [0.77, 1.79] 0.453 1.07 [0.66, 1.71] 0.784
Dietary factors
 Energy intake (k/Cal) (Ref: Below recommended)
  Within recommended 1.25 [0.89, 1.75] 0.432 1.03 [0.68, 1.57] 0.881
  Above recommended 1.13 [0.69,1.87] 0.161 0.93 [0.48, 1.81] 0.833
Total sugar intake (gm) 1.003 [1.00, 1.005] 0.042 1.00 [1.00, 1.01] 0.228
Clinical and biochemical factors
 Total cholesterol (Ref: Normal)
  Borderline/high (>=170mg/dL) 1.14 [0.79, 1.65] 0.463 1.07 [0.72, 1.59] 0.738
 HDL cholesterol (Ref: Normal)
  Low (<=45mg/dL) 1.41 [1.03, 1.92] 0.032 1.05 [0.75, 1.48] 0.757
C-reactive protein (3mg/L) 1.00 [0.97, 1.03] 0.997 0.99 [0.95, 1.02] 0.439
Systolic BP (mmHg) 1.02 [1.01, 1.03] 0.002 1.02 [0.98, 1.03] 0.109
Diastolic BP (mmHg) 1.02 [1.00, 1.04] 0.037 1.01 [0.98, 1.03] 0.647

WHR: Waist-to-height ratio; OR: Odds ratio; CI: confidence interval; BMI: Body mass index; HDL – High-density lipoprotein; BP – Blood pressure.

Multivariate analysis (after adjusting for confounders) identified three independent, significant predictors. Elevated waist-to-height ratio (central adiposity) emerged as the strongest independent predictor, with adolescents having over 146 times higher odds (AOR = 146.19, 95% CI: 5.39, 3976). BMI status, in contrast, lost significance in the multivariate model. Female gender was associated with lower odds (AOR = 0.52, 95% CI: 0.36, 0.78) compared to males. Older age was associated with lower odds (AOR = 0.91, 95% CI: 0.83, 0.99) of prediabetes/T2DM in adolescents.

Sensitivity analysis

Sensitivity analyses were conducted by sequentially adding covariates to examine the robustness of the association between overweight/obesity and abnormal glucose status. In the unadjusted model (Model 1), overweight/obesity was significantly associated with higher odds of abnormal glucose status (OR = 1.45, 95% CI: 1.10–1.79). After adjusting for socio-demographics and waist-to-height ratio (Model 2), the association was attenuated and became non-significant (OR = 0.76, 95% CI: 0.44–1.32). Further adjustment for physical activity and sedentary behavior (Model 3) yielded a similar non-significant result (OR = 0.77, 95% CI: 0.45–1.33). Finally, including dietary intake and metabolic markers (Model 4) did not change the pattern (OR = 0.74, 95% CI: 0.43–1.29), while age (OR = 0.91, 95% CI: 0.83–0.99), female sex (OR = 0.53, 95% CI: 0.36–0.78), and waist-to-height ratio (OR = 146.42, 95% CI: 5.39–3976.30) remained significant predictors. These results suggest that the observed relationship is influenced by demographic and metabolic factors, supporting the robustness of the study findings (S2 Table).

Discussion

This analysis of nationally representative NHANES data demonstrates a concerning prevalence of prediabetes/T2DM (30.8%) among U.S. adolescents, supporting previous evidence that abnormal glucose regulation is a major emerging public health issue in youth [1,20]. A critical observation is the disproportionate burden among males, who accounted for 62% of cases, compared to 38% among females. This sex disparity persisted even after multivariate adjustment, suggesting potential biological underpinnings such as greater visceral fat accumulation [21] and androgen-mediated insulin resistance [22]. This pattern aligns with U.S. and international studies [1,23,24] and a meta-analysis [25] reporting higher prediabetes/ T2DM prevalence in adolescent males, highlighting the potential importance of sex-specific preventive strategies.

One of the most striking findings is the strong predictive power of waist-to-height ratio for prediabetes/T2DM, consistent with global evidence showing high rates of overweight and obesity among youth with type 1 diabetes mellitus [26]. While overweight/obesity by BMI was associated with prediabetes/T2DM in univariate analysis, the association was attenuated and lost statistical significance after multivariate adjustment. In contrast, waist-to-height ratio remained highly significant, with an adjusted odds ratio exceeding 140, reflecting an exceptionally strong and independent association with early prediabetes/T2DM. Numerous studies support the superiority of waist-to-height ratio and waist circumference over BMI in predicting adiposity and cardiometabolic risk in youth [2729]. Consistent with our findings, Brambilla et al. demonstrated that waist-to-height ratio explained a greater proportion of variance in percent body fat (64%) than BMI (32%) among U.S. children and adolescents, with its predictive power increasing to 80% after adjusting for age and sex [27]. Similarly, Nambiar et al. (2010) found that waist-to-height ratio effectively identified Australian youth with elevated body fat and adverse cardiometabolic profiles, including higher triglycerides and lower HDL cholesterol [28]. These findings reinforce the growing evidence that waist-to-height ratio is a more reliable indicator of cardiometabolic risk than BMI in pediatric populations, particularly in detecting early signs of conditions such as prediabetes and T2DM.

Interestingly, lifestyle and dietary variables, including sedentary behavior, physical activity, total energy intake, and sugar consumption, did not persist as independent predictors of prediabetes/T2DM after multivariate adjustment. This finding contrasts with prevailing narratives linking the global rise in obesity to adverse lifestyle factors such as physical inactivity and the overconsumption of energy-dense, ultra-processed foods [3032]. This likely reflects that adiposity mediates much of the effect of lifestyle on glycemic outcomes, and that single-point self-reported behaviors may not adequately capture the cumulative exposure needed to influence early glycemic status. Furthermore, race and ethnicity were not significant predictors in this dataset, contrasting with prior reports of elevated risk in minority adolescents [4]. This may indicate that when obesity and central adiposity are accounted for, the independent effect of race on prediabetes/T2DM diminishes, or that the 2021–2023 NHANES cycle sample sizes limited subgroup detection power.

Implications

From a clinical and public health perspective, these findings suggest that screening strategies relying solely on BMI may miss high-risk adolescents. Integrating waist-to-height ratio into routine pediatric assessment could enhance early identification, particularly among males, and inform targeted interventions to reduce central adiposity before glycemic deterioration occurs.

Strengths and limitations

This study has notable strengths, including the use of recent, nationally representative data with standardized anthropometric and biochemical assessments, and a robust multivariable regression framework to isolate independent predictors. By directly contrasting BMI and waist-to-height ratio, the analysis contributes new evidence supporting waist-to-height ratio as a superior anthropometric marker for adolescent with prediabetes/T2DM in the U.S.

However, several limitations merit consideration. First, the cross-sectional design precludes causal inference between risk factors and prediabetes or T2DM. Second, the reliance on single-point fasting glucose and HbA1c measurements may misclassify glycemic status, as adolescents often exhibit variability. Third, dietary and activity measures are self-reported and may underestimate true exposure. Finally, the very wide confidence intervals for waist-to-height ratio indicate that while the association is strong, precision is limited, likely due to sparse events in certain subgroups, and should be interpreted cautiously.

Conclusion

Nearly 1-in-3 American adolescents has prediabetes or T2DM. Male gender and younger age showed increased risk. The findings underscore that central adiposity, specifically measured by waist-to-height ratio, is a superior and independent predictor of prediabetes/T2DM compared to general overweight/obesity (BMI). This highlights the critical need for early screening and targeted prevention strategies that incorporate waist-to-height ratio into routine pediatric assessment, focusing on central adiposity and demographic risk factors.

Supporting information

S1 Data. Imputed Stata dataset used for the analysis of prediabetes and diabetes among U.S. adolescents (NHANES 2021–2023).

(DTA)

pgph.0005596.s001.dta (7.9MB, dta)
S1 Table. Weighted prevalence of prediabetes and diabetes among US adolescents (10–19 years) in the NHANES fasting subsample (n = 571), stratified by key demographic and clinical variables.

(DOCX)

pgph.0005596.s002.docx (17.1KB, docx)
S2 Table. Sequential Logistic Regression Models Examining the Association Between Overweight/Obesity and Abnormal Glucose Status Among U.S. Adolescents (NHANES 2021–2023, MI = 20).

(DOCX)

pgph.0005596.s003.docx (16.8KB, docx)

Data Availability

The data used in this study are publicly available from the National Health and Nutrition Examination Survey (NHANES) website at https://www.cdc.gov/nchs/nhanes/index.html. Researchers can access the 2021–2023 datasets used in this analysis following NHANES data use policies.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Andes LJ, Cheng YJ, Rolka DB, Gregg EW, Imperatore G. Prevalence of prediabetes among adolescents and young adults in the United States, 2005-2016. JAMA Pediatr. 2020;174(2):e194498. doi: 10.1001/jamapediatrics.2019.4498 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Everett EM, Wright D, Williams A, Divers J, Pihoker C, Liese AD, et al. A longitudinal view of disparities in insulin pump use among youth with type 1 diabetes: The SEARCH for diabetes in youth study. Diabetes Technology & Therapeutics. 2023;25(2):131–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Franz MJ, Boucher JL, Rutten-Ramos S, VanWormer JJ. Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. J Acad Nutr Diet. 2015;115(9):1447–63. doi: 10.1016/j.jand.2015.02.031 [DOI] [PubMed] [Google Scholar]
  • 4.National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). NIDDK Recent Advances & Emerging Opportunities. 2024. http://www.niddk.nih.gov/about-niddk/strategic-plans-reports/niddk-recent-advancesemerging-opportunities [Google Scholar]
  • 5.American Diabetes Association Professional Practice Committee. 14. Children and Adolescents: Standards of Care in Diabetes-2025. Diabetes Care. 2025;48(1 Suppl 1):S283–305. doi: 10.2337/dc25-S014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.TODAY Study Group. Long-term complications in youth-onset type 2 diabetes. N Engl J Med. 2021;385(5):416–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Dabelea D, Stafford JM, Mayer-Davis EJ, D’Agostino R, Dolan L, Imperatore G. Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood. JAMA. 2017;317(8):825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. [DOI] [PubMed] [Google Scholar]
  • 9.Esquivel Zuniga R, DeBoer MD. Prediabetes in Adolescents: Prevalence, Management and Diabetes Prevention Strategies. Diabetes Metab Syndr Obes. 2021;14:4609–19. doi: 10.2147/DMSO.S284401 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ouyang A, Hu K, Chen L. Trends and risk factors of diabetes and prediabetes in US adolescents, 1999–2020. Diabetes Res Clin Pract. 2024;207:111022. [DOI] [PubMed] [Google Scholar]
  • 11.Yang C, Li S, Wu L, Ding Z, Zhou H, Pan Y. Prevalence of prediabetes by the fasting plasma glucose and HbA1c screening criteria among the children and adolescents of Shenzhen, China. Front Endocrinol. 2024;15:1301921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Jackson SL, Yang EC, Zhang Z. Income Disparities and Cardiovascular Risk Factors Among Adolescents. Pediatrics. 2018;142(5):e20181089. doi: 10.1542/peds.2018-1089 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ashwell M, Gibson S. Waist-to-height ratio as an indicator of “early health risk”: simpler and more predictive than using a “matrix” based on BMI and waist circumference. BMJ Open. 2016;6(3):e010159. doi: 10.1136/bmjopen-2015-010159 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Tremblay MS, LeBlanc AG, Kho ME, Saunders TJ, Larouche R, Colley RC, et al. Systematic review of sedentary behaviour and health indicators in school-aged children and youth. Int J Behav Nutr Phys Act. 2011;8:98. doi: 10.1186/1479-5868-8-98 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Merlo CL, Jones SE, Michael SL, Chen TJ, Sliwa SA, Lee SH. Dietary and physical activity behaviors among high school students — Youth Risk Behavior Survey, United States, 2019. MMWR Suppl. 2020;69(1):64–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Zhang N, Yang X, Zhu X, Zhao B, Huang T, Ji Q. Type 2 diabetes mellitus unawareness, prevalence, trends and risk factors: National Health and Nutrition Examination Survey (NHANES) 1999–2010. J Int Med Res. 2017;45(2):594–609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Casagrande SS, Lawrence JM. Cardiovascular disease risk factors and their associations with inflammation among US adolescents: NHANES, 2015 to March 2020. BMJ Open Diabetes Res Care. 2024;12(4):e004148. doi: 10.1136/bmjdrc-2024-004148 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M. Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499–511. [DOI] [PubMed] [Google Scholar]
  • 19.Shishehbor MH, Bhatt DL, Topol EJ. Using C-reactive protein to assess cardiovascular disease risk. Cleve Clin J Med. 2003;70(7):634–40. [DOI] [PubMed] [Google Scholar]
  • 20.Spurr S, Bally J, Allan D, Bullin C, McNair E. Prediabetes: An emerging public health concern in adolescents. Endocrinol Diabetes Metab. 2019;2(2):e00060. doi: 10.1002/edm2.60 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Staiano AE, Katzmarzyk PT. Ethnic and sex differences in body fat and visceral and subcutaneous adiposity in children and adolescents. Int J Obes (Lond). 2012;36(10):1261–9. doi: 10.1038/ijo.2012.95 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Puttabyatappa M, Sargis RM, Padmanabhan V. Developmental programming of insulin resistance: are androgens the culprits?. J Endocrinol. 2020;245(3):R23–48. doi: 10.1530/JOE-20-0044 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Kumar P, Srivastava S, Mishra PS, Mooss ETK. Prevalence of pre-diabetes/type 2 diabetes among adolescents (10-19 years) and its association with different measures of overweight/obesity in India: a gendered perspective. BMC Endocr Disord. 2021;21(1):146. doi: 10.1186/s12902-021-00802-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Tester J, Sharma S, Jasik CB, Mietus-Snyder M, Tinajero-Deck L. Gender differences in prediabetes and insulin resistance among 1356 obese children in Northern California. Diabetes Metab Syndr. 2013;7(3):161–5. doi: 10.1016/j.dsx.2013.06.002 [DOI] [PubMed] [Google Scholar]
  • 25.Han C, Song Q, Ren Y, Chen X, Jiang X, Hu D. Global prevalence of prediabetes in children and adolescents: A systematic review and meta-analysis. J Diabetes. 2022;14(7):434–41. doi: 10.1111/1753-0407.13291 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Peprah Osei E, Ekpor E, Osei GY, Akyirem S. Global prevalence and factors associated with overweight and obesity in children and adolescents with type 1 diabetes: a systematic review and meta-analysis. J Diabetes Metab Disord. 2025;24(2):257. doi: 10.1007/s40200-025-01774-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Brambilla P, Bedogni G, Heo M, Pietrobelli A. Waist circumference-to-height ratio predicts adiposity better than body mass index in children and adolescents. Int J Obes (Lond). 2013;37(7):943–6. doi: 10.1038/ijo.2013.32 [DOI] [PubMed] [Google Scholar]
  • 28.Nambiar S, Hughes I, Davies PS. Developing waist-to-height ratio cut-offs to define overweight and obesity in children and adolescents. Public Health Nutr. 2010;13(10):1566–74. doi: 10.1017/S1368980009993053 [DOI] [PubMed] [Google Scholar]
  • 29.Spolidoro JV, Pitrez Filho ML, Vargas LT, Santana JC, Pitrez E, Hauschild JA, et al. Waist circumference in children and adolescents correlate with metabolic syndrome and fat deposits in young adults. Clin Nutr. 2013;32(1):93–7. doi: 10.1016/j.clnu.2012.05.020 [DOI] [PubMed] [Google Scholar]
  • 30.Machado-Rodrigues AM, Padez C, Rodrigues D, Dos Santos EA, Baptista LC, Liz Martins M, et al. Ultra-Processed Food Consumption and Its Association with Risk of Obesity, Sedentary Behaviors, and Well-Being in Adolescents. Nutrients. 2024;16(22):3827. doi: 10.3390/nu16223827 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Pappachan JM, Fernandez CJ, Ashraf AP. Rising tide: The global surge of type 2 diabetes in children and adolescents demands action now. World J Diabetes. 2024;15(5):797–809. doi: 10.4239/wjd.v15.i5.797 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sultana S, Rahman MM, Sigel B, Hashizume M. Associations of lifestyle risk factors with overweight or obesity among adolescents: a multicountry analysis. Am J Clin Nutr. 2021;113(3):742–50. doi: 10.1093/ajcn/nqaa337 [DOI] [PubMed] [Google Scholar]
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0005596.r001

Decision Letter 0

Doreen Larvie

30 Oct 2025

PGPH-D-25-02293

Prevalence and predictors of prediabetes/type 2 diabetes in adolescents in the United States: Data from NHANES (2021-2023)

PLOS Global Public Health

Dear Dr. Peprah Osei,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 29 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Doreen Larvie, Ph.D

Academic Editor

PLOS Global Public Health

Journal Requirements:

1. Please ensure that your Ethics Statement is available in its entirety at the beginning of your Methods section, under a subheading 'Ethics Statement'. It must include:

1) The name(s) of the Institutional Review Board(s) or Ethics Committee(s)

2) The approval number(s), or a statement that approval was granted by the named board(s)

3) (for human participants/donors) - A statement that formal consent was obtained (must state whether verbal/written) OR the reason consent was not obtained (e.g. anonymity).

2. Please provide separate figure files in .tif or .eps format.

For more information about figure files please see our guidelines:

https://journals.plos.org/globalpublichealth/s/figures

https://journals.plos.org/globalpublichealth/s/figures#loc-file-requirements

3. We have noticed that you have uploaded Supporting Information files, but you have not included a list of legends. Please add a full list of legends for your Supporting Information files after the references list.

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does this manuscript meet PLOS Global Public Health’s publication criteria?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?-->?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: Thank you for the opportunity to review this manuscript. The manuscript is well written and provides a timely update on risk factors for prediabetes and diabetes among a nationally representative sample of adolescents in the United States. I have the following comments for consideration prior to publication:

Methods:

1) While I agree with the author that categorizing glucose status into “normal” and “prediabetes/diabetes” status allows for a more efficient analysis, I do not agree with the author’s statement that is allows for a more thorough analysis. In fact, I think grouping them in this way could hide meaningful differences in risk factors for prediabetes versus diabetes.

2) In a similar vein, I understand the purpose of grouping prediabetes/diabetes into one outcome due to the relatively small sample size. While separating the outcomes into “prediabetes” and “diabetes” would result in reduced statistical power, it could be an interesting sensitivity analysis to see if there are any unique risk factors for prediabetes and diabetes, respectively.

3) The author categorizes energy intake into four quartiles (<1396KCAL, 1396-1837.9KCAL, 1838-2388.9KCAL, >=2389 KCAL). Was there any consideration for whether the energy intake levels were appropriate for an individual’s age/sex? Perhaps the author could consider creating a category of consuming less than recommended KCAL, consuming recommended KCAL, consuming more than recommended KCAL, based on age and sex.

4) In the clinical and biochemical factors paragraph, the author writes “elevated BP is defined as SBP of 120-129 mmHg and DBP < 80mmHg”. This seems incorrect.

5) In the final paragraph of the methods, the author reports on collinearity and variance inflation factors. This should be in the results section under a “modeling assumptions” subsection.

Results:

1) The author relies too heavily on p-values

2) The author provides p-values in Table 1 to evaluate whether there are statistically significant differences in baseline demographics. However, the use of p-values to evaluate such differences should be avoided and removed in alignment with guidelines from the American Statistical Association (https://amstat.tandfonline.com/doi/pdf/10.1080/00031305.2016.1154108 ) and the ICMJE (http://www.icmje.org/recommendations/browse/manuscript-preparation/preparing-for-submission.html).

3) Do not bold statistically significant results in a table, this can be misleading and result in readers overlooking potentially important or interesting findings.

4) The author reports that table 2 represents “weighted” prevalence but weighting is never discussed in the methods section. Please clarify how results were weighted.

Additional comment from editor: The methods section should clearly indicate whether NHANES survey weights and design variables (sampling weights, strata, PSUs) were used in the analysis. If not, please justify this approach, as unweighted analyses may not yield representative or unbiased results.

5) When reporting results and stating differences between groups please report the prevalence rates for each group rather than the p-value to indicate meaningful difference. For example, “…adolescents with overweight/obesity and those with abdominal obesity showed significantly higher prevalence rates (36.4% and 36.7%, respectively” than their healthier-weight counterparts (X%)”. The p-value does not tell us anything about how clinically meaningful the prevalence difference is.

6) Similarly, when reporting results of logistic regression analysis please report confidence intervals instead of p-values.

7) It is interesting that the effect of BMI status reverses direction in the multivariate analysis (though the confidence interval overlaps with the univariate CI). The author should consider whether there is the potential for collider bias (https://jamanetwork.com/journals/jama/fullarticle/2790247) in the multivariate regression.

Reviewer #2: This study analyzed data from 1,998 U.S. adolescents (10–19 years) from the National Health and Nutrition Examination Surveys (NHANES, 2021–2023) to determine the prevalence and predictors of prediabetes/type 2 diabetes.

Key Findings

The overall weighted prevalence of prediabetes or diabetes was a concerning 30.8%, meaning nearly 1-in-3 American adolescents has the condition.

Prevalence Disparities:

Prevalence was significantly higher in males (38.1%) compared to females (23.4%).

Mexican American (33.6%) and Other Hispanic (33.3%) adolescents had the highest rates across racial/ethnic groups.

Adolescents with overweight/obesity (36.4%) and abdominal obesity (waist-to-height ratio \ge 0.5) (36.7%) showed significantly higher prevalence.

Predictors of Prediabetes/Diabetes

Univariate Analysis found several significant associations:

Lower odds: Older age (OR=0.93, p=0.045) and female gender (OR=0.50, p=0.001).

Higher odds: Overweight/obesity (OR=1.57, p=0.012), elevated waist-to-height ratio (OR=24.04, p=0.002), total daily sugar intake (OR=1.003, p=0.042), low \text{HDL cholesterol} (\le 45 \text{ mg/dL}) (OR=1.41, p=0.032), higher systolic BP, and higher diastolic BP.

Multivariate Analysis (after adjusting for confounders) identified three independent, significant predictors:

Elevated Waist-to-Height Ratio (Central Adiposity): This emerged as the strongest independent predictor, with adolescents having over 146 times higher odds (AOR=146.19, p=0.004). BMI status, in contrast, lost significance in the multivariate model.

Female Gender: Associated with lower odds (AOR=0.52, p=0.002) compared to males.

Older Age: Associated with lower odds (AOR=0.91, p=0.025).

Conclusion and Implications

Nearly 1-in-3 American adolescents has diabetes or prediabetes. Male gender and younger age showed increased risk. The findings underscore that central adiposity, specifically measured by waist-to-height ratio, is a superior and independent predictor of prediabetes/diabetes compared to general overweight/obesity (BMI). This highlights the critical need for early screening and targeted prevention strategies that incorporate waist-to-height ratio into routine pediatric assessment, focusing on central adiposity and demographic risk factors

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0005596.r003

Decision Letter 1

Doreen Larvie

19 Nov 2025

Prevalence and predictors of prediabetes/type 2 diabetes in adolescents in the United States: Data from NHANES (2021-2023)

PGPH-D-25-02293R1

Dear Mr Peprah Osei,

We are pleased to inform you that your manuscript 'Prevalence and predictors of prediabetes/type 2 diabetes in adolescents in the United States: Data from NHANES (2021-2023)' has been provisionally accepted for publication in PLOS Global Public Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact globalpubhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Global Public Health.

Best regards,

Doreen Larvie, Ph.D

Academic Editor

PLOS Global Public Health

***********************************************************

Reviewer Comments (if any, and for reference):

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data. Imputed Stata dataset used for the analysis of prediabetes and diabetes among U.S. adolescents (NHANES 2021–2023).

    (DTA)

    pgph.0005596.s001.dta (7.9MB, dta)
    S1 Table. Weighted prevalence of prediabetes and diabetes among US adolescents (10–19 years) in the NHANES fasting subsample (n = 571), stratified by key demographic and clinical variables.

    (DOCX)

    pgph.0005596.s002.docx (17.1KB, docx)
    S2 Table. Sequential Logistic Regression Models Examining the Association Between Overweight/Obesity and Abnormal Glucose Status Among U.S. Adolescents (NHANES 2021–2023, MI = 20).

    (DOCX)

    pgph.0005596.s003.docx (16.8KB, docx)
    Attachment

    Submitted filename: Response to reviewers.docx

    pgph.0005596.s005.docx (23KB, docx)

    Data Availability Statement

    The data used in this study are publicly available from the National Health and Nutrition Examination Survey (NHANES) website at https://www.cdc.gov/nchs/nhanes/index.html. Researchers can access the 2021–2023 datasets used in this analysis following NHANES data use policies.


    Articles from PLOS Global Public Health are provided here courtesy of PLOS

    RESOURCES